Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
TrialScope Disclose keeps you ahead of changing regulations and evolving expectations, empowering you to maintain global disclosure compliance from a single, centralized platform
How it helps
Everyone benefits from better transparency around clinical trials. But in a complex and ever-evolving regulatory landscape, navigating the clinical trial disclosure process can be difficult for even the most diligent sponsors. With TrialScope Disclose you can:
How it works
TrialScope Disclose is powered by an intelligent disclosure rules engine that uses automation to keep you compliant across registries, even as regulations evolve. TrialScope Disclose will automatically:
Professional Disclosure Services
We’re here to help your organization master the complexities of disclosure any way we can — including doing the work for you. Our team of experts can act as an extension of your team, and take your most time-consuming, cumbersome disclosure activities off your plate — from protocol registration through results posting — so you’re free to focus on the big picture.
TrialScope Disclose
31 Mar 2023
The coronavirus pandemic put clinical trials in the spotlight — or hot seat, depending on one’s perspective. Around the globe pressure came from multiple fronts: regulatory agencies, the public, patients, advocates, pharmaceutical industry watchdogs and investors all clamored for increased clinical transparency. The push for accountability has not abated for study sponsors to publish results in a timely manner. However, just as there are numerous regulatory agencies and guidelines (approximately 90 countries have requirements related to the disclosure of clinical trial data made publicly available on over 30 clinical trial registries), enforcement of clinical trial disclosure requirements varies greatly.
TrialScope Disclose
31 Mar 2022
Clinical trial disclosure experts Francine Lane and Thomas Wicks provide an overview of EU CTR/CTIS regulations and timelines for compliance.
Topic Market Intelligence
TrialScope Disclose
31 Mar 2022
Disclosure & transparency experts from Sarepta, Boehringer Ingelheim, Bayer and Merck KGaA discuss the ins and outs of CTIS.
Topic Regulation
TrialScope Disclose
07 Feb 2022
Disclosure requirements are numerous and ever evolving. Study sponsors need a transparency policy that addresses disclosure, transparency, and data sharing.
Topic Policy & Regulation
TrialScope Disclose
11 Jan 2022
Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.
TrialScope Disclose
19 Oct 2021
Europe’s new Clinical Trial Information System (CTIS), created by the European Medicines Agency (EMA), is due to be implemented in January 2022. Find out what sponsors must do to ensure compliance with this far-reaching new regulatory requirement.
Topic Clinical Trials
TrialScope Disclose
14 Sep 2021
Created by the European Medicines Agency (EMA). Stakeholders will use CTIS to: Submit and approve clinical trial applications (CTAs), Submit trial reports, results and notifications, Communicate centrally with the Member States Concerned (MSC) in the clinical trial
Topic Policy & Regulation Clinical Trials Clinical Trials Blog
Pharmaprojects, Trialtrove, Citeline, TrialScope Disclose
19 Aug 2021
Download your free infographic for a snapshot view of UK vs. EU4 clinical landscape
Darcy specializes in
9+ years of experience
Over 450,000 investigators from 170,000+ sites in 180+ countries, all with clinical trial experience, at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove.
Key benefits:
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
TrialScope Disclose
31 Mar 2023
The coronavirus pandemic put clinical trials in the spotlight — or hot seat, depending on one’s perspective. Around the globe pressure came from multiple fronts: regulatory agencies, the public, patients, advocates, pharmaceutical industry watchdogs and investors all clamored for increased clinical transparency. The push for accountability has not abated for study sponsors to publish results in a timely manner. However, just as there are numerous regulatory agencies and guidelines (approximately 90 countries have requirements related to the disclosure of clinical trial data made publicly available on over 30 clinical trial registries), enforcement of clinical trial disclosure requirements varies greatly.
TrialScope Disclose
31 Mar 2022
Clinical trial disclosure experts Francine Lane and Thomas Wicks provide an overview of EU CTR/CTIS regulations and timelines for compliance.
Topic Market Intelligence
TrialScope Disclose
31 Mar 2022
Disclosure & transparency experts from Sarepta, Boehringer Ingelheim, Bayer and Merck KGaA discuss the ins and outs of CTIS.
Topic Regulation
TrialScope Disclose
07 Feb 2022
Disclosure requirements are numerous and ever evolving. Study sponsors need a transparency policy that addresses disclosure, transparency, and data sharing.
Topic Policy & Regulation
TrialScope Disclose
11 Jan 2022
Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.
TrialScope Disclose
19 Oct 2021
Europe’s new Clinical Trial Information System (CTIS), created by the European Medicines Agency (EMA), is due to be implemented in January 2022. Find out what sponsors must do to ensure compliance with this far-reaching new regulatory requirement.
Topic Clinical Trials
TrialScope Disclose
14 Sep 2021
Created by the European Medicines Agency (EMA). Stakeholders will use CTIS to: Submit and approve clinical trial applications (CTAs), Submit trial reports, results and notifications, Communicate centrally with the Member States Concerned (MSC) in the clinical trial
Topic Policy & Regulation Clinical Trials Clinical Trials Blog
Pharmaprojects, Trialtrove, Citeline, TrialScope Disclose
19 Aug 2021
Download your free infographic for a snapshot view of UK vs. EU4 clinical landscape
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
